• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

埃德蒙森分级可预测肝原发性透明细胞癌患者根治性切除术后的生存率:一项长期随访的回顾性研究

Edmondson grade predicts survival of patients with primary clear cell carcinoma of liver after curative resection: A retrospective study with long-term follow-up.

作者信息

Xu Wei, Ge Penglei, Liao Wenjun, Ren Jinjun, Yang Huayu, Xu Haifeng, Sang Xinting, Lu Xin, Zhong Shouxian, Mao Yilei

机构信息

Department of Liver Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

出版信息

Asia Pac J Clin Oncol. 2017 Oct;13(5):e312-e320. doi: 10.1111/ajco.12494. Epub 2016 Apr 21.

DOI:10.1111/ajco.12494
PMID:27098441
Abstract

AIM

Primary clear cell carcinoma of liver (PCCCL) is a specific and rare subtype of primary hepatocellular carcinoma (HCC). We performed a retrospective study with long-term follow-up to investigate predictive factors and prognosis of intrahepatic recurrences of PCCCL after radical resection.

METHODS

We retrospectively analyzed records of 38 patients with PCCCL who were diagnosed at Peking Union Medical College Hospital between January 1989 and September 2010, with a long-term follow up to January 2015, to determine their clinical characteristics and postoperative survival. The data were compared with 400 patients received radical hepatectomy for common type hepatocellular carcinoma (CHCC) during the study period.

RESULTS

PCCCL tumors were smaller than those of CHCC (P < 0.001) and the incidence of vascular invasion of tumors in PCCCL group was significantly lower than that in CHCC (P = 0.029). The 1-, 3-, and 5-year overall survival (OS) for PCCCL patients were 94.6%, 67.3%, and 58.5%, respectively; 1-, 3-, and 5-year disease-free survival (DFS) were 89.2%, 54.1%, and 48.6%, respectively. Both OS and DFS were significantly better for PCCCL patients than for CHCC (P = 0.039 and 0.044). Cox modeling showed high Edmondson grade to be the only independent predictive factor for survival of PCCCL patients, which were different from those of CHCC.

CONCLUSIONS

PCCCL is a less malignant subtype of HCC than CHCC, patients with PCCCL likely have later intrahepatic recurrences and a better prognosis. Edmondson grade predicts survival of patients with PCCCL after curative resection; those with higher Edmondson grades may require more careful follow-up and aggressive post-hepatectomy therapy.

摘要

目的

肝原发性透明细胞癌(PCCCL)是原发性肝细胞癌(HCC)一种特殊且罕见的亚型。我们进行了一项长期随访的回顾性研究,以探讨PCCCL根治性切除术后肝内复发的预测因素及预后。

方法

我们回顾性分析了1989年1月至2010年9月在北京协和医院确诊的38例PCCCL患者的记录,并对其进行长期随访至2015年1月,以确定他们的临床特征和术后生存情况。将这些数据与研究期间接受根治性肝切除术的400例普通型肝细胞癌(CHCC)患者的数据进行比较。

结果

PCCCL肿瘤比CHCC肿瘤小(P < 0.001),PCCCL组肿瘤血管侵犯发生率显著低于CHCC组(P = 0.029)。PCCCL患者1年、3年和5年总生存率(OS)分别为94.6%、67.3%和58.5%;1年、3年和5年无病生存率(DFS)分别为89.2%、54.1%和48.6%。PCCCL患者的OS和DFS均显著优于CHCC患者(P = 0.039和0.044)。Cox模型显示高Edmondson分级是PCCCL患者生存的唯一独立预测因素,这与CHCC不同。

结论

与CHCC相比,PCCCL是HCC中恶性程度较低的亚型,PCCCL患者肝内复发可能较晚,预后较好。Edmondson分级可预测PCCCL患者根治性切除术后的生存情况;Edmondson分级较高的患者可能需要更密切的随访和积极的肝切除术后治疗。

相似文献

1
Edmondson grade predicts survival of patients with primary clear cell carcinoma of liver after curative resection: A retrospective study with long-term follow-up.埃德蒙森分级可预测肝原发性透明细胞癌患者根治性切除术后的生存率:一项长期随访的回顾性研究
Asia Pac J Clin Oncol. 2017 Oct;13(5):e312-e320. doi: 10.1111/ajco.12494. Epub 2016 Apr 21.
2
Risk factors, prognosis, and management of early and late intrahepatic recurrence after resection of primary clear cell carcinoma of the liver.原发性肝透明细胞癌切除术后早、晚期肝内复发的危险因素、预后及处理。
Ann Surg Oncol. 2011 Jul;18(7):1955-63. doi: 10.1245/s10434-010-1540-z. Epub 2011 Jan 15.
3
[Clinicopathological and prognostic analysis of primary clear cell carcinoma of the liver].[肝脏原发性透明细胞癌的临床病理及预后分析]
Zhonghua Zhong Liu Za Zhi. 2013 Feb;35(2):140-3. doi: 10.3760/cma.j.issn.0253-3766.2013.02.015.
4
Influence of clear cell carcinoma on the post-hepatectomy prognosis of patients with hepatocellular carcinoma.透明细胞癌对肝癌患者肝切除术后预后的影响。
Future Oncol. 2022 Feb;18(5):543-552. doi: 10.2217/fon-2021-0381. Epub 2021 Dec 8.
5
Primary clear cell carcinoma in the liver: CT and MRI findings.肝脏原发性透明细胞癌:CT 和 MRI 表现。
World J Gastroenterol. 2011 Feb 21;17(7):946-52. doi: 10.3748/wjg.v17.i7.946.
6
Development and Identification of a Nomogram Prognostic Model for Patients with Primary Clear Cell Carcinoma of the Liver.原发性肝透明细胞癌患者列线图预后模型的建立与鉴定。
Med Sci Monit. 2020 Jan 23;26:e919789. doi: 10.12659/MSM.919789.
7
Longterm prognosis of combined hepatocellular carcinoma-cholangiocarcinoma following liver transplantation and resection.肝移植和切除术后肝细胞癌-胆管癌合并症的长期预后
Liver Transpl. 2017 Mar;23(3):330-341. doi: 10.1002/lt.24711.
8
Combined hepatocellular carcinoma and cholangiocarcinoma: clinical features, treatment modalities, and prognosis.肝细胞癌合并胆管细胞癌:临床特征、治疗方式和预后。
Ann Surg Oncol. 2012 Sep;19(9):2869-76. doi: 10.1245/s10434-012-2328-0. Epub 2012 Mar 27.
9
Minor versus major hepatic resection for small hepatocellular carcinoma (HCC) in cirrhotic patients: a 20-year experience.小肝癌患者行肝段切除术或肝叶切除术:20 年经验回顾
Surgery. 2010 May;147(5):676-85. doi: 10.1016/j.surg.2009.10.043. Epub 2009 Dec 11.
10
Edmondson-Steiner grade: A crucial predictor of recurrence and survival in hepatocellular carcinoma without microvascular invasio.埃德蒙森-施泰纳分级:无微血管侵犯的肝细胞癌复发和生存的关键预测指标。
Pathol Res Pract. 2017 Jul;213(7):824-830. doi: 10.1016/j.prp.2017.03.002. Epub 2017 Mar 8.

引用本文的文献

1
lncRNA POLR2J4 Plays a Biomarker Role in Hepatitis B Virus-Related Hepatocellular Carcinoma Through Regulating miR-214-3p.lncRNA POLR2J4 通过调节 miR-214-3p 在乙型肝炎病毒相关肝细胞癌中发挥生物标志物作用。
Turk J Gastroenterol. 2024 Aug 26;35(10):787-794. doi: 10.5152/tjg.2024.24150.
2
Clear cell hepatocellular carcinoma: Gd-EOB-DTPA-enhanced MR imaging features and prognosis.透明细胞型肝细胞癌:钆塞酸二钠增强磁共振成像特征与预后。
Abdom Radiol (NY). 2024 Aug;49(8):2606-2621. doi: 10.1007/s00261-024-04263-2. Epub 2024 Apr 1.
3
Diagnosis of primary clear cell carcinoma of the liver based on Faster region-based convolutional neural network.
基于 Faster 区域卷积神经网络的肝原发性透明细胞癌诊断。
Chin Med J (Engl). 2023 Nov 20;136(22):2706-2711. doi: 10.1097/CM9.0000000000002853. Epub 2023 Oct 25.
4
Advances in Histological and Molecular Classification of Hepatocellular Carcinoma.肝细胞癌组织学和分子分类的进展
Biomedicines. 2023 Sep 20;11(9):2582. doi: 10.3390/biomedicines11092582.
5
Epidemiological and Clinical Characteristics of Five Rare Pathological Subtypes of Hepatocellular Carcinoma.肝细胞癌五种罕见病理亚型的流行病学及临床特征
Front Oncol. 2022 Apr 8;12:864106. doi: 10.3389/fonc.2022.864106. eCollection 2022.
6
Predictors and survival of primary clear cell carcinoma of liver: a population-based study of an uncommon primary liver tumor.肝原发性透明细胞癌的预测因素与生存情况:一项基于人群的罕见原发性肝癌研究
Transl Cancer Res. 2021 Jul;10(7):3326-3344. doi: 10.21037/tcr-21-9.
7
Effect of surgical margin on postoperative prognosis in patients with solitary hepatocellular carcinoma: A propensity score matching analysis.手术切缘对孤立性肝细胞癌患者术后预后的影响:一项倾向评分匹配分析
J Cancer. 2021 May 27;12(15):4455-4462. doi: 10.7150/jca.57896. eCollection 2021.
8
Hepatocellular carcinoma: making sense of morphological heterogeneity, growth patterns, and subtypes.肝细胞癌:解析形态异质性、生长模式和亚型。
Hum Pathol. 2021 Jun;112:86-101. doi: 10.1016/j.humpath.2020.12.009. Epub 2020 Dec 30.
9
Sunitinib-and-Chinese herbal medicine-based systematic treatment clinically cured a patient with multiple metastatic primary clear cell carcinoma of the liver: a case report.基于舒尼替尼和中药的系统治疗临床治愈了一名多发性转移性原发性肝透明细胞癌患者:病例报告
Onco Targets Ther. 2019 Apr 12;12:2823-2828. doi: 10.2147/OTT.S197923. eCollection 2019.
10
Changing role of histopathology in the diagnosis and management of hepatocellular carcinoma.组织病理学在肝细胞癌诊断和治疗中的角色转变。
World J Gastroenterol. 2018 Sep 21;24(35):4000-4013. doi: 10.3748/wjg.v24.i35.4000.